Ra Medical Systems Inc. (RMED) shares are trading at lower $0.25 and the avg recommendation for the stock is Moderate Buy.
To add more color to this target, the company’s high over the last year is $2.69 and the low is $0.23. Over the last 52 weeks, RMED is down -85.30% while the S&P 500 is up 10.88%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, RMED reported a profit of $-0.27 million. Ra Medical Systems Inc. also saw revenues decrease to $0.9 million. In addition, RMED has free cash flow of -$12.89 million as of 06-2020. The company’s EBITDA came in at -$9.48 million which compares well with its peers.
RMED Return on Equity (ROE) is -140.20%, and its Return on Assets is -102.80%. All told, it is clear that, RMED needs to be on your watchlist.
Find out when RMED reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. RMED has a short ratio of 0.44 and outstanding shares of 72.47M.
RMED has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at -3.01. Ra Medical Systems Inc. RMED also noted assets of $40.69 million at the end of the last quarter. Investors should also keep an eye on sector updates as RMED has historically followed its peers on positive news.
All told, Ra Medical Systems Inc. RMED has strung together solid data and demonstrated underlying fundamentals. At its current valuation, RMED represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Ra Medical Systems Inc. RMED is now commanding a market cap of 18.19M and a float of 64.66M. RMED is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of RMED stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in RMED, either long or short, and we have not been compensated for this article.